Table 2.

Self‐Reported Management of Nonvalvular Atrial Fibrillation

Case Scenario	Case 1			Case 2			Case 3			Case 4			Case 5			Case 6			Case 7			Case 8
Drug Treatment Choices	n	% HK	% AUS	n	% HK	% AUS	n	% HK	% AUS	n	% HK	% AUS	n	% HK	% AUS	n	% HK	% AUS	n	% HK	% AUS	n	% HK	% AUS
Aspirin	40	64.5	31.2	27	43.5	4.4	31	50.0	16.1	3	4.8	2.9	23	37.1	19.0	9	14.5	2.9	15	24.2	15.6	15	24.2	9.6
Warfarin	8	12.9	61.7	25	40.3	88.8	22	35.5	73.3	34	54.8	71.0	15	24.2	45.6	7	11.3	17.1	18	29.0	28.9	1	1.6	9.6
Clopidogrel	1	1.6	1.8	2	3.2	1.0	2	3.2	2.7	1	1.6	5.2	5	8.1	12.1	19	30.6	59.4	9	14.5	35.1	9	14.5	20.8
Aspirin and clopidogrel	1	1.6	2.7	1	1.6	1.5	2	3.2	4.9	6	9.7	9.1	8	12.9	15.9	5	8.1	2.0	5	8.1	5.9	5	8.1	4.5
Aspirin and warfarin	1	1.6	1.0	3	4.8	3.9	2	3.2	2.3	15	24.2	11.2	4	6.5	5.4	1	1.6	0.2	4	6.5	2.2	1	1.6	0.7
No antithrombotic treatment	9	14.5	1.3	2	3.2	0.3	0	0	0.3	0	0	0	2	3.2	1.0	19	30.6	17.4	9	14.5	11.2	29	46.8	52.3
Missing	2	3.2		2	3.2		3	4.8		3	4.8		5	8.1		2	3.2		2	3.2		2	3.2

Abbreviations: AUS, Australian; HK, Hong Kong.

Data source of Australian family physicians: Gattellari et al.10